116 related articles for article (PubMed ID: 31173384)
1. Histological assessment of stromal maturity as a prognostic factor in surgically treated gastric adenocarcinoma.
Kemi NA; Eskuri M; Pohjanen VM; Karttunen TJ; Kauppila JH
Histopathology; 2019 Dec; 75(6):882-889. PubMed ID: 31173384
[TBL] [Abstract][Full Text] [Related]
2. Tumour-stroma ratio and prognosis in gastric adenocarcinoma.
Kemi N; Eskuri M; Herva A; Leppänen J; Huhta H; Helminen O; Saarnio J; Karttunen TJ; Kauppila JH
Br J Cancer; 2018 Aug; 119(4):435-439. PubMed ID: 30057407
[TBL] [Abstract][Full Text] [Related]
3. Tumor Budding and Prognosis in Gastric Adenocarcinoma.
Kemi N; Eskuri M; Ikäläinen J; Karttunen TJ; Kauppila JH
Am J Surg Pathol; 2019 Feb; 43(2):229-234. PubMed ID: 30334831
[TBL] [Abstract][Full Text] [Related]
4. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
5. Tumour budding and tumour-stroma ratio in hepatocellular carcinoma.
Kairaluoma V; Kemi N; Pohjanen VM; Saarnio J; Helminen O
Br J Cancer; 2020 Jul; 123(1):38-45. PubMed ID: 32362654
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of tumour-stroma ratio in endometrial carcinoma.
Panayiotou H; Orsi NM; Thygesen HH; Wright AI; Winder M; Hutson R; Cummings M
BMC Cancer; 2015 Dec; 15():955. PubMed ID: 26674153
[TBL] [Abstract][Full Text] [Related]
7. Radiographical assessment of tumour stroma and treatment outcomes using deep learning: a retrospective, multicohort study.
Jiang Y; Liang X; Han Z; Wang W; Xi S; Li T; Chen C; Yuan Q; Li N; Yu J; Xie Y; Xu Y; Zhou Z; Poultsides GA; Li G; Li R
Lancet Digit Health; 2021 Jun; 3(6):e371-e382. PubMed ID: 34045003
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
[TBL] [Abstract][Full Text] [Related]
9. High PROX1 expression in gastric cancer predicts better survival.
Laitinen A; Böckelman C; Hagström J; Kokkola A; Kallio P; Haglund C
PLoS One; 2017; 12(8):e0183868. PubMed ID: 28854215
[TBL] [Abstract][Full Text] [Related]
10. Increased RhoA Activity Predicts Worse Overall Survival in Patients Undergoing Surgical Resection for Lauren Diffuse-Type Gastric Adenocarcinoma.
Chang KK; Cho SJ; Yoon C; Lee JH; Park DJ; Yoon SS
Ann Surg Oncol; 2016 Dec; 23(13):4238-4246. PubMed ID: 27364501
[TBL] [Abstract][Full Text] [Related]
11. Survival outcome associated with the screening interval for gastric cancer in Korea.
Lee H; Min BH; Lee JH; Son HJ; Kim JJ; Rhee JC; Kim S; Rhee PL
Digestion; 2011; 84(2):142-8. PubMed ID: 21525769
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of Tumour Budding and Desmoplastic Reaction in Intestinal-Type Gastric Adenocarcinoma.
Pun C; Luu S; Swallow C; Kirsch R; Conner JR
Int J Surg Pathol; 2023 Sep; 31(6):957-966. PubMed ID: 35726174
[No Abstract] [Full Text] [Related]
13. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes and prognostic factors in gastric cancer patients aged ≥85 years undergoing endoscopic submucosal dissection.
Sekiguchi M; Oda I; Suzuki H; Abe S; Nonaka S; Yoshinaga S; Taniguchi H; Sekine S; Saito Y
Gastrointest Endosc; 2017 May; 85(5):963-972. PubMed ID: 27751873
[TBL] [Abstract][Full Text] [Related]
15. Revisiting a dogma: similar survival of patients with small bowel and gastric GIST. A population-based propensity score SEER analysis.
Guller U; Tarantino I; Cerny T; Ulrich A; Schmied BM; Warschkow R
Gastric Cancer; 2017 Jan; 20(1):49-60. PubMed ID: 26649434
[TBL] [Abstract][Full Text] [Related]
16. Presence of cancer cells in gastric lavage of gastric cancer patients as an indicator of advanced disease, predictor of tumour aggressive phenotype and independent prognostic factor for poor survival: The endoluminal metastatic pathway of gastric cancer and GL0/GL1 classification.
Virgilio E; Giarnieri E; Giovagnoli MR; Montagnini M; Proietti A; D'Urso R; Nigri G; Mercantini P; Ramacciato G; Cavallini M; Balducci G
Cytopathology; 2018 Feb; 29(1):41-48. PubMed ID: 29063636
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].
Li B; Sun L; Wang X; Deng J; Ding X; Wang X; Ke B; Zhang L; Zhang R; Liang H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):207-212. PubMed ID: 28226357
[TBL] [Abstract][Full Text] [Related]
18. Histological categorisation of fibrotic cancer stroma in advanced rectal cancer.
Ueno H; Jones AM; Wilkinson KH; Jass JR; Talbot IC
Gut; 2004 Apr; 53(4):581-6. PubMed ID: 15016755
[TBL] [Abstract][Full Text] [Related]
19. Prognostic importance of RASSF2 expression in patients with gastric cancer who had undergone radical gastrectomy.
Aydin D; Bilici A; Kayahan S; Yavuzer D; Basar M; Aliustaoglu M
Clin Transl Oncol; 2016 Jun; 18(6):608-16. PubMed ID: 26459248
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of cathepsin D expression in gastric adenocarcinoma.
Ikeguchi M; Fukuda K; Oka S; Yamaguchi K; Hisamitsu K; Tsujitani S; Sakatani T; Ueda T; Kaibara N
Oncology; 2001; 61(1):71-8. PubMed ID: 11474252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
